Fuller & Thaler Asset Management’s Medpace MEDP Stock Holding History

Fuller & Thaler Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$35.4M	Sell	73,655 -3,222	-4%	-$1.65M	0.12%	230
2025 Q4	$43.2M	Buy	76,877 +3,847	+5%	+$2.18M	0.15%	216
2025 Q3	$37.5M	Buy	73,030 +1,154	+2%	+$504K	0.13%	225
2025 Q2	$22.6M	Sell	71,876 -12,126	-14%	-$3.64M	0.08%	251
2025 Q1	$25.6M	Sell	84,002 -17,729	-17%	-$5.96M	0.1%	241
2024 Q4	$33.8M	Sell	101,731 -128,668	-56%	-$43.6M	0.13%	227
2024 Q3	$76.9M	Sell	230,399 -85,851	-27%	-$32.6M	0.3%	112
2024 Q2	$130M	Sell	316,250 -1,454	-0.5%	-$576K	0.56%	49
2024 Q1	$128M	Sell	317,704 -127,034	-29%	-$44.7M	0.56%	56
2023 Q4	$136M	Sell	444,738 -193,716	-30%	-$52.3M	0.69%	38
2023 Q3	$155M	Sell	638,454 -304,816	-32%	-$78M	0.89%	21
2023 Q2	$227M	Buy	943,270 +3,325	+0.4%	+$691K	1.29%	11
2023 Q1	$177M	Buy	939,945 +1,747	+0.2%	+$361K	1.02%	17
2022 Q4	$199M	Buy	938,198 +124,314	+15%	+$24.8M	1.27%	12
2022 Q3	$128M	Buy	813,884 +333,184	+69%	+$53.2M	0.92%	23
2022 Q2	$71.9M	Sell	480,700 -13,791	-3%	-$2M	0.5%	69
2022 Q1	$80.9M	Sell	494,491 -956	-0.2%	-$158K	0.48%	70
2021 Q4	$108M	Buy	495,447 +15,064	+3%	+$3.15M	0.63%	47
2021 Q3	$90.9M	Buy	480,383 +65,218	+16%	+$11.9M	0.59%	54
2021 Q2	$73.3M	Buy	415,165 +10,862	+3%	+$1.87M	0.48%	71
2021 Q1	$66.3M	Sell	404,303 -160,248	-28%	-$24.5M	0.47%	74
2020 Q4	$78.6M	Sell	564,551 -305,844	-35%	-$38.5M	0.73%	37
2020 Q3	$97.3M	Buy	870,395 +7,741	+0.9%	+$895K	1.23%	13
2020 Q2	$80.2M	Buy	862,654 +135,838	+19%	+$11.6M	1.05%	18
2020 Q1	$53.3M	Buy	726,816 +157,308	+28%	+$13.7M	0.9%	29
2019 Q4	$47.9M	Buy	569,508 +19,699	+4%	+$1.52M	0.53%	66
2019 Q3	$46.2M	Sell	549,809 -5,883	-1%	-$445K	0.55%	66
2019 Q2	$36.4M	Buy	555,692 +227,991	+70%	+$13.1M	0.42%	84
2019 Q1	$19.3M	Sell	327,701 -470,813	-59%	-$28.1M	0.24%	114
2018 Q4	$42.3M	Buy	798,514 +176,052	+28%	+$9.66M	0.61%	58
2018 Q3	$37.3M	Buy	+622,462	New	+$34M	0.39%	87

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fuller & Thaler Asset Management's MEDP Position: Q1 2026 in Review

Fuller & Thaler Asset Management reduced its Medpace (MEDP) stake by 4.2% in Q1 2026, selling an estimated $1.65M and leaving 73,655 shares worth $35.4M. The position accounts for 0.12% of the portfolio, ranked #230.

Fuller & Thaler Asset Management first reported a position in MEDP in Q3 2018 and has held it in 31 quarters since. The position peaked at $227M in Q2 2023. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

Fuller & Thaler Asset Management held 73,655 shares of Medpace worth $35.4M as of Q1 2026.
Fuller & Thaler Asset Management sold 3,222 Medpace shares in Q1 2026, an estimated $1.65M.
Medpace made up 0.12% of Fuller & Thaler Asset Management's portfolio in Q1 2026, its #230 holding.
Fuller & Thaler Asset Management first reported a position in Medpace in Q3 2018 and has held it in 31 quarters since.
Fuller & Thaler Asset Management's Medpace position peaked at $227M in Q2 2023.
729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2026, filed 14 May 2026.